iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · Real-Time Price · USD
3.480
-0.150 (-4.13%)
At close: Feb 21, 2025, 4:00 PM
3.490
+0.010 (0.29%)
After-hours: Feb 21, 2025, 7:59 PM EST
iBio, Inc. Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 0.38 | 0.23 | - | 1.88 | 2.37 | 1.64 | Upgrade
|
| Revenue Growth (YoY) | 650.00% | - | - | -20.54% | 44.75% | -18.83% | Upgrade
|
| Cost of Revenue | - | - | - | - | 1.46 | 0.7 | Upgrade
|
| Gross Profit | 0.38 | 0.23 | - | 1.88 | 0.91 | 0.94 | Upgrade
|
| Selling, General & Admin | 10.71 | 11.67 | 18.45 | 21.75 | 21.89 | 11.37 | Upgrade
|
| Research & Development | 5.23 | 5.19 | 10.33 | 9.83 | 9.99 | 3.57 | Upgrade
|
| Operating Expenses | 15.94 | 16.86 | 28.78 | 31.58 | 31.88 | 14.94 | Upgrade
|
| Operating Income | -15.56 | -16.63 | -28.78 | -29.7 | -30.97 | -14 | Upgrade
|
| Interest Expense | -0.23 | -0.17 | -0.08 | - | -2.45 | -2.47 | Upgrade
|
| Interest & Investment Income | 0.55 | 0.36 | 0.21 | 0.18 | 0.14 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -15.23 | -16.44 | -28.65 | -29.51 | -33.27 | -16.44 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.1 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1 | 1 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | -0.57 | - | -0.14 | - | Upgrade
|
| Legal Settlements | - | - | - | - | 10.2 | - | Upgrade
|
| Pretax Income | -14.23 | -15.44 | -29.31 | -29.51 | -23.21 | -16.44 | Upgrade
|
| Earnings From Continuing Operations | -14.23 | -15.44 | -29.31 | -29.51 | -23.21 | -16.44 | Upgrade
|
| Earnings From Discontinued Operations | -5.07 | -9.46 | -35.7 | -20.79 | - | - | Upgrade
|
| Net Income to Company | -19.3 | -24.91 | -65.01 | -50.3 | -23.21 | -16.44 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0 | 0.01 | 0.01 | Upgrade
|
| Net Income | -19.3 | -24.91 | -65.01 | -50.3 | -23.21 | -16.44 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 0.09 | 0.26 | 21.82 | Upgrade
|
| Net Income to Common | -19.3 | -24.91 | -65.01 | -50.39 | -23.47 | -38.26 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 4 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 4 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 557.77% | 525.98% | 40.35% | 11.45% | 211.53% | 231.79% | Upgrade
|
| EPS (Basic) | -2.57 | -6.50 | -106.23 | -115.56 | -59.98 | -304.64 | Upgrade
|
| EPS (Diluted) | -2.57 | -6.50 | -106.23 | -115.56 | -59.98 | -304.64 | Upgrade
|
| Free Cash Flow | -16.3 | -18.76 | -36.87 | -44.81 | -34.98 | -14.42 | Upgrade
|
| Free Cash Flow Per Share | -2.17 | -4.90 | -60.24 | -102.76 | -89.42 | -114.84 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | 100.00% | 38.34% | 57.08% | Upgrade
|
| Operating Margin | -4149.33% | -7392.89% | - | -1576.27% | -1306.12% | -854.88% | Upgrade
|
| Profit Margin | -5147.47% | -11069.78% | - | -2674.68% | -989.75% | -2335.78% | Upgrade
|
| Free Cash Flow Margin | -4347.47% | -8339.56% | - | -2378.45% | -1475.50% | -880.53% | Upgrade
|
| EBITDA | -14.71 | -15.71 | -28.05 | -29.3 | -28.55 | -11.76 | Upgrade
|
| D&A For EBITDA | 0.85 | 0.93 | 0.73 | 0.4 | 2.41 | 2.24 | Upgrade
|
| EBIT | -15.56 | -16.63 | -28.78 | -29.7 | -30.97 | -14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.